ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW 550.00
-6.00 (-1.08%)
At close: Aug 4, 2026
KOSDAQ:034940 Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2,825 | 2,325 | 2,097 | 2,047 | 4,526 | 5,749 |
Short-Term Investments | 199.74 | 198.12 | 2,549 | 1,538 | 1,537 | 1,587 |
Trading Asset Securities | - | - | 800.73 | 775.02 | 2,386 | 2,849 |
Cash & Short-Term Investments | 3,025 | 2,523 | 5,447 | 4,361 | 8,449 | 10,184 |
Cash Growth | 64.35% | -53.69% | 24.93% | -48.39% | -17.04% | 12.59% |
Accounts Receivable | 17,576 | 17,808 | 18,250 | 20,230 | 22,727 | 20,884 |
Other Receivables | 1,934 | 1,671 | 1,818 | 2,593 | 2,731 | 2,359 |
Receivables | 19,922 | 19,923 | 20,948 | 23,900 | 27,603 | 24,867 |
Inventory | 11,729 | 11,717 | 12,446 | 13,012 | 10,869 | 10,286 |
Prepaid Expenses | - | 96.25 | 204.88 | 87.45 | 94.42 | 118.8 |
Other Current Assets | 1,035 | 792.76 | 693.01 | 796.44 | 1,183 | 1,048 |
Total Current Assets | 35,711 | 35,052 | 39,740 | 42,157 | 48,200 | 46,504 |
Property, Plant & Equipment | 17,358 | 19,067 | 19,712 | 20,370 | 24,999 | 24,074 |
Long-Term Investments | 2,985 | 3,534 | 3,068 | 2,792 | 2,935 | 3,678 |
Goodwill | - | - | - | - | - | 46.78 |
Other Intangible Assets | 559.42 | 549.56 | 769 | 803.4 | 806.87 | 795.5 |
Long-Term Accounts Receivable | - | - | 0 | 1,054 | 1,054 | - |
Long-Term Deferred Tax Assets | 365.47 | 365.47 | 1,370 | 1,499 | 1,401 | 945.32 |
Other Long-Term Assets | 5,860 | 5,916 | 6,662 | 5,544 | 6,028 | 4,049 |
Total Assets | 63,039 | 64,683 | 71,320 | 74,221 | 85,639 | 80,512 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3,596 | 3,486 | 4,865 | 5,501 | 4,994 | 3,685 |
Accrued Expenses | - | 3,080 | 3,516 | 3,494 | 2,765 | 2,775 |
Short-Term Debt | 20,550 | 22,105 | 20,750 | 14,550 | 14,554 | 12,794 |
Current Portion of Long-Term Debt | 1,409 | 905.51 | 448.61 | - | - | - |
Current Portion of Leases | 638.25 | 564.54 | 629.07 | 633.15 | 637.5 | 684.07 |
Current Unearned Revenue | - | 73.84 | 140.5 | 153.42 | 122.27 | 88.1 |
Other Current Liabilities | 6,763 | 5,545 | 6,306 | 4,847 | 4,255 | 4,236 |
Total Current Liabilities | 32,956 | 35,759 | 36,656 | 29,178 | 27,328 | 24,263 |
Long-Term Debt | 3,007 | 1,973 | 1,576 | 1,105 | 1,904 | 1,000 |
Long-Term Leases | 1,955 | 1,757 | 1,285 | 1,213 | 1,583 | 1,996 |
Pension & Post-Retirement Benefits | 1,639 | 1,435 | 1,301 | 545.82 | - | 1,328 |
Other Long-Term Liabilities | 1,863 | 1,991 | 1,941 | 3,422 | 3,417 | 3,542 |
Total Liabilities | 41,420 | 42,916 | 42,759 | 35,464 | 34,231 | 32,129 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 15,490 | 15,490 | 15,490 | 15,490 | 15,490 | 15,490 |
Additional Paid-In Capital | 63,621 | 63,621 | 63,621 | 63,621 | 63,621 | 63,621 |
Retained Earnings | -54,154 | -54,180 | -47,817 | -38,175 | -26,354 | -29,255 |
Comprehensive Income & Other | 76.47 | 74.02 | 81.67 | 57.07 | 86.29 | 64.05 |
Total Common Equity | 25,034 | 25,005 | 31,376 | 40,993 | 52,844 | 49,920 |
Minority Interest | -3,415 | -3,239 | -2,815 | -2,235 | -1,436 | -1,537 |
Shareholders' Equity | 21,619 | 21,767 | 28,561 | 38,758 | 51,408 | 48,383 |
Total Liabilities & Equity | 63,039 | 64,683 | 71,320 | 74,221 | 85,639 | 80,512 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 27,559 | 27,305 | 24,689 | 17,501 | 18,678 | 16,474 |
Net Cash (Debt) | -24,534 | -24,782 | -19,242 | -13,141 | -10,229 | -6,289 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -792.74 | -799.95 | -621.05 | -424.17 | -330.17 | -203.02 |
Filing Date Shares Outstanding | 30.98 | 30.98 | 30.98 | 30.98 | 30.98 | 30.98 |
Total Common Shares Outstanding | 30.98 | 30.98 | 30.98 | 30.98 | 30.98 | 30.98 |
Working Capital | 2,755 | -707.59 | 3,084 | 12,979 | 20,872 | 22,242 |
Book Value Per Share | 808.07 | 807.15 | 1012.78 | 1323.22 | 1705.75 | 1611.38 |
Tangible Book Value | 24,474 | 24,456 | 30,607 | 40,190 | 52,037 | 49,078 |
Tangible Book Value Per Share | 790.01 | 789.41 | 987.96 | 1297.29 | 1679.70 | 1584.20 |
Land | 7,396 | 8,811 | 8,811 | 8,864 | 9,408 | 9,329 |
Buildings | 3,007 | 14,615 | 14,756 | 14,739 | 18,178 | 18,129 |
Machinery | 4,302 | 30,795 | 30,693 | 30,233 | 26,893 | 26,807 |
Construction In Progress | 346.63 | 508.12 | - | 7.24 | 4,157 | 1,430 |